Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa
- 1 October 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 31 (4) , 612-617
- https://doi.org/10.1016/s0168-8278(99)80339-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Reinforced regiment of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomized trialJournal of Hepatology, 1998
- Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis CHepatology, 1998
- Quantification of the initial decline of serum hepatitis c virus RNA and response to interferon alfaHepatology, 1998
- Cytotoxic T cells and viral hepatitis.Journal of Clinical Investigation, 1997
- Detection of Type 2–Like T–Helper Cells in Hepatitis C Virus Infection: Implications for Hepatitis C Virus ChronicityHepatology, 1997
- Progressive Liver Injury in Chronic Hepatitis C Infection Correlates With Increased Intrahepatic Expression of Th1–Associated CytokinesHepatology, 1996
- Immunoregulatory Cytokines in Chronic Hepatitis C Virus Infection: Pre– and Posttreatment With Interferon AlfaHepatology, 1996
- Serum levels of soluble interleukin-2 receptors and effects of interferon-α for patients with chronic hepatitis C virusDigestive Diseases and Sciences, 1995
- Serum Levels of Soluble Interleukin-2 Receptor in Chronic Hepatitis C Treated with Interferon-AlphaScandinavian Journal of Gastroenterology, 1995
- Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-αDigestive Diseases and Sciences, 1994